2492423-29-5 (莫努皮拉韦,Molnupiravir)

Molnupiravir;EIDD 2801;EIDD2801;YA84KI1VEW;Eidd 1931-isopropyl ester;Molnupiravir [USAN];((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate;WHO 11853;((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyr;EIDD-2801;MFCD32663515;EIDD-1931 ISOPROPYL ESTER;Molnupiravir (JAN/USAN);AKOS040758956;N-hydroxy-5'-O-(2-methylpropanoyl)-3,4-dihydrocytidine;med.21724, Compound 182;Lagevrio (TN);MOLNUPIRAVIR [JAN];Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-;2349386-89-4;CHEMBL4650320;AS-84465;MK-4482;((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;EIDD 1931 5'-isopropylester;N-hydroxy-5'-O-(2-methylpropanoyl)cytidine;[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3H-pyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate;2635324-86-4;G70664;s8969;2492423-29-5;BCP32744;((2r,3s,4r,5r)-3,4-dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidine-1(2h)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;UNII-YA84KI1VEW;N(4)-hydroxycytidine 5'-isopropylester;((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;pro-EIDD-1931;Molnupiravir [USAN:INN:WHO-DD];TS-09789;Lagevrio;SCHEMBL23762545;EIDD 2801; EIDD2801; Uridine, 4-oxime, 5'-(2-methylpropanoate;EIDD-2801(Molnupiravir)?;Molnupiravir [WHO-DD];CHEBI:180653;((2R,3S,4R,5R)-3,4-Dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4- dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate;C13H19N3O7;SARS-CoV-2 antiviral agents: molnupiravir;[(2R,3S,4R,5R)-3,4-dihydroxy-5-[(4E)-4-(hydroxyimino)-2-oxo-1,2,3,4-tetrahydropyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate;((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl 2-methylpropanoate;beta-D-N4 Hydroxycytidine-5'-isopropyl ester;DTXSID501028058;((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate;Molnupiravir [INN];.BETA.-D-N4 HYDROXYCYTIDINE-5'-ISOPROPYL ESTER;EX-A3432;SCHEMBL26089644;BDBM429508;MK4482;{(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl]tetrahydrofuran-2-yl}methyl 2-methylpropanoate;MK 4482;D11943;XMO;GTPL10737;1ST178990;EIDD-2801(Molnupiravir);N4-Hydroxycytidine, 5'-isopropyl ester;molnupiravirum;Uridine, 4-oxime, 5'-(2-methylpropanoate);AT13078;AC-35171;beta-D-N(4)-hydroxycytidine-5'-isopropyl ester;

MFCD32663515

HTNPEHXGEKVIHG-QCNRFFRDSA-N

1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1

O1[C@]([H])([C@@]([H])([C@@]([H])([C@@]1([H])C([H])([H])OC(C([H])(C([H])([H])[H])C([H])([H])[H])=O)O[H])O[H])N1C(N=C(C([H])=C1[H])N([H])O[H])=O